Catheters Market

Executive Summary

Catheters Market was valued at US $22.01 billion in 2021 and is projected to grow at 10.59% CAGR over the forecast period to reach US $40.26 billion by 2027. Catheters Market represented US $4.01 billion opportunity over 2019-2021 and estimated to create US $18.25 billion opportunity in 2027 over 2021.

Catheters from Consainsights analyses the Catheters Market in the Life Sciences industry over the forecast period to 2027.

Catheters research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Catheters segmentation includes Type, End User, Region and Geography.

Based on the Type, the Catheters analysis covers Cardiovascular Catheters, Intravenous Catheters, Urological Catheters, Specialty Catheters, Neurovascular Catheters.

In Type segment, Cardiovascular Catheters segment has highest cagr growth of 9.36%.

Based on the End User, the Catheters analysis covers Hospitals, Long-Term Care Facilities, Diagnostic Imaging Centers, Other End Users.

In End User segment, Hospitals segment has highest cagr growth of 9.36%.

Based on the Region, the Catheters analysis covers North America, Europe, Asia Pacific, RoW.

In Region segment, North America segment has highest cagr growth of 9.36%.

Based on the region, the Catheters analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, Abbott, B. Braun Melsungen AG, ConvaTec Group PLC, Coloplast Group, Cook Medical, Edwards Lifesciences Corporation, Johnson & Johnson Services, Merit Medical Systems, Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Hollister Incorporated, AMG International GmbH, Simeks Tibbi Ürünler, Alvimedica, Medinol Ltd, Amsino International, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Cardiovascular Catheters segment has the highest revenue of US $9.85 billion and is expected to grow at CAGR of 9.36% by 2027 Cardiovascular Catheters segment has highest cagr growth of 9.36%.

Cardiovascular Catheters

Cardiovascular Catheters segment was valued at US $8.05 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $18.01 billion by 2027. Cardiovascular Catheters segment represented US $1.80 billion opportunity over 2019-2021 and estimated to create US $8.17 billion opportunity in 2027 over 2021.

Intravenous Catheters

Intravenous Catheters segment was valued at US $4.18 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $9.36 billion by 2027. Intravenous Catheters segment represented US $0.93 billion opportunity over 2019-2021 and estimated to create US $4.24 billion opportunity in 2027 over 2021.

Urological Catheters

Urological Catheters segment was valued at US $2.32 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $5.20 billion by 2027. Urological Catheters segment represented US $0.52 billion opportunity over 2019-2021 and estimated to create US $2.36 billion opportunity in 2027 over 2021.

Specialty Catheters

Specialty Catheters segment was valued at US $2.00 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $4.46 billion by 2027. Specialty Catheters segment represented US $0.44 billion opportunity over 2019-2021 and estimated to create US $2.02 billion opportunity in 2027 over 2021.

Neurovascular Catheters

Neurovascular Catheters segment was valued at US $1.44 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $3.22 billion by 2027. Neurovascular Catheters segment represented US $0.32 billion opportunity over 2019-2021 and estimated to create US $1.46 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $11.18 billion and is expected to grow at CAGR of 9.36% by 2027 Hospitals segment has highest cagr growth of 9.36%.

Hospitals

Hospitals segment was valued at US $9.14 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $20.44 billion by 2027. Hospitals segment represented US $2.04 billion opportunity over 2019-2021 and estimated to create US $9.27 billion opportunity in 2027 over 2021.

Long-Term Care Facilities

Long-Term Care Facilities segment was valued at US $6.00 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $13.42 billion by 2027. Long-Term Care Facilities segment represented US $1.34 billion opportunity over 2019-2021 and estimated to create US $6.08 billion opportunity in 2027 over 2021.

Diagnostic Imaging Centers

Diagnostic Imaging Centers segment was valued at US $2.00 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $4.47 billion by 2027. Diagnostic Imaging Centers segment represented US $0.45 billion opportunity over 2019-2021 and estimated to create US $2.03 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.86 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $1.93 billion by 2027. Other End Users segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.87 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $10.30 billion and is expected to grow at CAGR of 9.36% by 2027 North America segment has highest cagr growth of 9.36%.

North America

North America segment was valued at US $8.42 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $18.83 billion by 2027. North America segment represented US $1.88 billion opportunity over 2019-2021 and estimated to create US $8.54 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $4.83 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $10.81 billion by 2027. Europe segment represented US $1.08 billion opportunity over 2019-2021 and estimated to create US $4.90 billion opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $2.97 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $6.65 billion by 2027. Asia Pacific segment represented US $0.66 billion opportunity over 2019-2021 and estimated to create US $3.01 billion opportunity in 2027 over 2021.

RoW

RoW segment was valued at US $1.77 billion in 2019 and is projected to grow at 9.36% CAGR over the forecast period to reach US $3.97 billion by 2027. RoW segment represented US $0.40 billion opportunity over 2019-2021 and estimated to create US $1.80 billion opportunity in 2027 over 2021.